Esperion Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2024: 0.00x

Esperion Therapeutics Inc cash flow reinvestment rate. Esperion Therapeutics Inc (ESPR) has a Cash Flow Reinvestment Rate of 0.00x as of March 2024, reinvesting $146.00K (capex $73.00K plus investments $-73.00K) from operating cash flow of $53.83 Million. Explore Esperion Therapeutics Inc (ESPR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$146.00K

Capex + Investments

Operating Cash Flow

$53.83 Million

USD

Capital Expenditures

$73.00K

USD

Esperion Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)

Esperion Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Esperion Therapeutics Inc. For the full cash flow conversion analysis, see Esperion Therapeutics Inc (ESPR) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow